Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide.
作者信息
Hopkins Ashley M, Vitry Agnes I, O'Doherty Catherine E, Proudman Susanna M, Wiese Michael D
机构信息
Sansom Institute for Health Research, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia.
Department of Rheumatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
出版信息
Int J Rheum Dis. 2017 Nov;20(11):1795-1797. doi: 10.1111/1756-185X.12717. Epub 2015 Jul 14.
PMID:26176865
Abstract
摘要
Zotero 插件